Corona Remedies Stock Surges Over 35% on Market Debut

• Corona Remedies shares made a remarkable market debut, closing over 35% higher than their issue price of Rs 1,062.
• The stock listed at Rs 1,452 on BSE and Rs 1,470 on NSE, showing a significant premium.
• The company's market valuation reached Rs 8,789.93 crore on its debut day.
• Corona Remedies' Initial Public Offering (IPO) was oversubscribed 137.04 times, raising Rs 655.37 crore.
• Headquartered in Ahmedabad, Corona Remedies is a pharmaceutical formulation company.

Why It Matters: It signals strong investor confidence and potential for significant gains.